Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Syros Pharmaceuticals (NQ: SYRS ) 6.060 -0.470 (-7.20%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Syros Pharmaceuticals < Previous 1 2 3 4 5 6 7 8 9 Next > Syros to Host Webcast Event on Higher-Risk Myelodysplastic Syndrome and the Opportunity for Tamibarotene to Become the New Frontline Standard-of-Care for Patients with RARA Gene Overexpression June 13, 2024 From Syros Pharmaceuticals Via Business Wire SYRS Stock Earnings: Syros Pharmaceuticals Beats EPS for Q1 2024 May 14, 2024 SYRS stock results show that Syros Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Syros Reports First Quarter 2024 Financial Results and Provides a Corporate Update May 14, 2024 From Syros Pharmaceuticals Via Business Wire Syros to Participate in Upcoming Investor Conferences May 07, 2024 From Syros Pharmaceuticals Via Business Wire Syros Pharmaceuticals's Earnings Outlook March 26, 2024 Via Benzinga Syros to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024 May 07, 2024 From Syros Pharmaceuticals Via Business Wire Crude Oil Down Over 1%; Cognyte Software Shares Plummet April 09, 2024 U.S. stocks traded lower toward the end of trading, with the S&P 500 falling around 0.4% on Tuesday. The Dow traded down 0.46% to 38,713.72 while the NASDAQ fell 0.24% to 16,215.32. The S&P 500 also... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities 12 Health Care Stocks Moving In Tuesday's Intraday Session April 09, 2024 Via Benzinga Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Newly Diagnosed Unfit AML with RARA gene overexpression April 09, 2024 From Syros Pharmaceuticals Via Business Wire Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 09, 2024 Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter estimates and said it no longer expects to generate positive adjusted free Via Benzinga Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 02, 2024 From Syros Pharmaceuticals Via Business Wire Top 3 Health Care Stocks You'll Regret Missing This Month April 02, 2024 The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. Via Benzinga SYRS Stock Earnings: Syros Pharmaceuticals Misses EPS, Misses Revenue for Q4 2023 March 27, 2024 SYRS stock results show that Syros Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. Via InvestorPlace Syros Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update March 27, 2024 From Syros Pharmaceuticals Via Business Wire Syros Announces Completion of Enrollment of 190 Patients Necessary to Support Primary Endpoint Analysis in SELECT-MDS-1 Phase 3 Trial March 25, 2024 From Syros Pharmaceuticals Via Business Wire Earnings Scheduled For March 27, 2024 March 27, 2024 Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on revenue of $8.70 million. Via Benzinga Syros to Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 27, 2024 March 20, 2024 From Syros Pharmaceuticals Via Business Wire A Look Into Healthcare Sector Value Stocks March 11, 2024 Via Benzinga Syros to Participate in TD Cowen 44th Annual Health Care Conference February 27, 2024 From Syros Pharmaceuticals Via Business Wire Overview Of Value Stocks In The Healthcare Sector February 12, 2024 Via Benzinga 3 Once-in-a-Lifetime Penny Stocks With Unprecedented Surge Potential January 31, 2024 Is your portfolio is in dire need of making new all-time highs? A new economic cycle is to send these penny stocks with potential up. Via InvestorPlace 5 Value Stocks To Watch In The Healthcare Sector January 29, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session January 09, 2024 Via Benzinga Syros Highlights Anticipated 2024 Milestones to Deliver on the Value of Tamibarotene January 08, 2024 From Syros Pharmaceuticals Via Business Wire 5 Value Stocks To Watch In The Healthcare Sector January 01, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session December 19, 2023 Via Benzinga Syros Announces Pricing of $45.0 million Underwritten Offering of Common Stock and Pre-Funded Warrants December 19, 2023 From Syros Pharmaceuticals Via Business Wire Why Is Blood Cancer Focused Syros Pharmaceuticals Stock Soaring Today? December 06, 2023 Syros Pharmaceuticals Inc (NASDAQ: SYRS) released initial data from its ongoing SELECT-AML-1 Phase 2 trial of tamibarotene in combination with venetoclax and azacitidine in newly diagnosed, unfit... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session December 06, 2023 Via Benzinga Syros Announces Encouraging Initial Data from Randomized SELECT-AML-1 Phase 2 Clinical Trial Evaluating Tamibarotene in Combination with Venetoclax and Azacitidine December 06, 2023 From Syros Pharmaceuticals Via Business Wire < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.